The assay was reworked as a consequence ... and third- and fourth-generation tests offer very high performances. Immunoassays must be correctly selected and used for the population being tested.

Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

A team of biomolecular engineers, pathologists, and internal medicine specialists at the University of Texas Medical Branch, ...

Emerging drug-resistant strains are posing significant challenges to the global fight against tuberculosis (TB) and it is a critical task to detect treatment failure as early as possible.

The test, which runs on the Swiss company's high-throughput MosaiQ System, detects 15 different autoantibodies.

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration ...